Loading viewer...
investor_presentation
Format: PDF investor_presentation
Fulgent Genetics, Inc. (NASDAQ: FLGT) presented its 2024 investor update covering its molecular diagnostics and genetic testing services, plus its Fulgent Pharma subsidiary focused on cancer care solutions. The presentation outlines the company's business model, leadership team, and strategic initiatives in genomic diagnostics and pharmaceutical development.
investor_presentation
21 Pages
Assertio Holdings
IOL Chemicals and Pharmaceuticals Q4 FY23 Investor Presentation 2023
investor_presentationinvestor_presentation
31 Pages
IOL Chemicals and Pharmaceuticals Limited
Tessco Technologies Investor Presentation — November 2020
investor_presentationinvestor_presentation
66 Pages
TESSCO Technologies, Incorporated
Iovance Biotherapeutics Investor Presentation — June 2019
investor_presentationinvestor_presentation
24 Pages
Iovance Biotherapeutics, Inc